Literature DB >> 12488697

Saccharomyces: is it a probiotic or a pathogen and what is the significance of an elevated anti-S. cerevisiae antibody?

Martin H Floch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12488697     DOI: 10.1097/00004836-200301000-00003

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  5 in total

1.  Anti-Saccaromyces Cerevisiae antibodies (ASCA) are elevated in autoimmune thyroid disease ASCA in autoimmune thyroid disease.

Authors:  Dilek Yazıcı; Sibel Zehra Aydın; Dilek Yavuz; Ozlem Tarçın; Oğuzhan Deyneli; Haner Direskeneli; Sema Akalın
Journal:  Endocrine       Date:  2010-07-16       Impact factor: 3.633

Review 2.  Cell signals, cell contacts, and the organization of yeast communities.

Authors:  Saul M Honigberg
Journal:  Eukaryot Cell       Date:  2011-02-04

3.  Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.

Authors:  Michele Malaguarnera; Marco Vacante; Tijana Antic; Maria Giordano; Giuseppe Chisari; Rosaria Acquaviva; Silvana Mastrojeni; Giulia Malaguarnera; Antonio Mistretta; Giovanni Li Volti; Fabio Galvano
Journal:  Dig Dis Sci       Date:  2011-09-08       Impact factor: 3.199

4.  Correlation between Saccharomyces cerevisiae DNA in intestinal mucosal samples and anti-Saccharomyces cerevisiae antibodies in serum of patients with IBD.

Authors:  R-C Mallant-Hent; M Mooij; B-Me von Blomberg; R-K Linskens; A-A van Bodegraven; P-Hm Savelkoul
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

5.  Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.

Authors:  Govind K Makharia; Vikas Sachdev; Rajiva Gupta; Suman Lal; R M Pandey
Journal:  Dig Dis Sci       Date:  2006-12-08       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.